Direct-acting antivirals for chronic hepatitis C: risk of hypoglycaemia in patients with diabetes

2018-12-18T12:43:45+00:00

Monitor glucose levels closely in patients with diabetes during direct-acting antiviral therapy for hepatitis C, particularly within the first 3 months of treatment, and modify diabetes medication or doses when necessary. Pa…